Top Insider Tidings
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
No Result
View All Result
Top Insider Tidings
No Result
View All Result
Home Editor's Pick

DOJ removes Ed Martin from Trump admin’s Weaponization Working Group amid increased activity

by
February 3, 2026
in Editor's Pick
0
DOJ removes Ed Martin from Trump admin’s Weaponization Working Group amid increased activity

The Justice Department (DOJ) has removed its pardon attorney from an internal ‘Weaponization Working Group,’ even as officials say the politically sensitive panel is now meeting more frequently, Fox News has learned.

Ed Martin currently serves as the DOJ’s pardon attorney, a role appointed by President Donald Trump that involves reviewing clemency applications and advising the White House on pardons and commutations. He had also participated in the department’s internal Weaponization Working Group.

A DOJ spokesperson confirmed to Fox News on Monday that Martin had been removed from the working group, though it was not immediately clear why.

‘President Trump appointed Ed Martin as Pardon Attorney and Ed continues to do a great job in that role,’ a DOJ spokesperson said.

Trump nominated Martin, a former defense attorney who represented Americans charged in the Jan. 6, 2021, riot at the U.S. Capitol, to serve as U.S. attorney for the District of Columbia in February of last year.

But after concerns from lawmakers stalled Martin’s confirmation, Trump withdrew the nomination.

Trump instead nominated Jeanine Pirro for the role, and she was ultimately confirmed.

Martin was appointed to serve as U.S. pardon attorney on May 14, 2025, and was named by Trump at the time to serve as director of the Justice Department’s Weaponization Working Group, a role he held until his removal was announced Monday.

The working group was formed in early 2025 and is now meeting more frequently, with the goal of eventually meeting daily. It is an internal review body created to examine claims that federal law enforcement and prosecutorial powers were misused for political or partisan purposes.

Martin has previously drawn scrutiny over his actions involving New York Attorney General Letitia James. In August, a lawyer representing James criticized Martin for visiting her Brooklyn residence and publicly suggesting she resign, calling the visit a ‘made-for-media stunt.’

Martin later said he visited the property to ‘lay eyes on it’ and shared images of the visit on social media.

He was subsequently granted special prosecutorial authority to pursue mortgage fraud investigations involving James and Sen. Adam Schiff, D-Calif., both of whom have denied wrongdoing and described the probes as politically motivated.

Martin also urged James to step down in a letter he described as ‘confidential’ but later shared publicly on X.

This post appeared first on FOX NEWS
Previous Post

Fox News Digital report spurs 22 AGs to urge expanded House probe into alleged judicial bias

Next Post

Costa Rica swings right as voters embrace tough-on-crime leader amid surging violence

Next Post
Costa Rica swings right as voters embrace tough-on-crime leader amid surging violence

Costa Rica swings right as voters embrace tough-on-crime leader amid surging violence

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent News

    Meta, Google face massive liability as ‘addicted kids’ trial continues in LA

    Meta, Google face massive liability as ‘addicted kids’ trial continues in LA

    February 11, 2026
    Vance warns Iran that ‘another option on the table’ if nuclear deal not reached

    Vance warns Iran that ‘another option on the table’ if nuclear deal not reached

    February 11, 2026
    Trump, Netanyahu to meet at White House in high-stakes talks on Iran, Gaza plan

    Trump, Netanyahu to meet at White House in high-stakes talks on Iran, Gaza plan

    February 11, 2026
    FDA refuses to review Moderna’s mRNA flu vaccine application

    FDA refuses to review Moderna’s mRNA flu vaccine application

    February 11, 2026
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TopInsiderTidings.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 topinsidertidings.com | All Rights Reserved

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Editor’s Pick

    Disclaimer: TopInsiderTidings.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.